T0	Limitation 28661 28670	Estimated
T1	Limitation 31116 31119	The
T2	Limitation 31297 31301	This
T3	Limitation 31435 31443	Although
T4	Limitation 32300 32305	Study
T5	Limitation 32462 32475	Additionally,
T6	UnderpoweredStudy 28789 28873	the study was not powered to show a statistical difference in the ACR response rates
T7	SampleSize 31155 31207	the small number of patients in each treatment group
T8	UnderpoweredStudy 31212 31295	the resultant lack of statistical power for comparisons beyond the primary endpoint
T9	SampleSize 31297 31319	This small sample size
T10	DiagnosticCriteria 31332 31373	the heterogeneity of the study population
T11	ExperimentalPhaseDuration 32300 32314	Study duration
#1	AnnotatorNotes T11	ShortStudyLength
T12	VerySpecificPopulation 32491 32590	all patients had previously been treated with, and failed to respond to, at least one TNF inhibitor
T13	Generalization 32602 32677	results seen here may not be directly applicable to the wider RA population
T14	PrecisionOfMeasurement 31560 31682	results in these groups (while demonstrating overall consistency with previous published RA clinical trials) were variable
T15	Intervention 31507 31555	they received identical treatments at all visits
